Genmont Biotech Inc. (3164)
Market Closed
15 Jun, 05:30
TWSE TWSE Primary NT$
16. 40
+0.05
+0.3058%
NT$
1.59B Market Cap
- P/E Ratio
0.8% Div Yield
31,155 Volume
- Eps
NT$ 16.35
Previous Close Want to track 3164 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.12 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.24 |
| | | - | 0.37 |
| | | - | 0.34 |
| | | - | - |
3164 Earnings Reports FAQ
What is the earnings per share (EPS) for 3164?
EPS data for 3164 is currently not available, as Genmont Biotech Inc has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately -39.3%, reflecting the 3164's performance and TWSE market conditions.
When is the next earnings release date?
Genmont Biotech Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Genmont Biotech Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 3164 at this time, as Genmont Biotech Inc has no recent EPS data to calculate it.
